Berchuck A - Search Results

1

Spillman MA, Berchuck A. Spillman MA, et al. Among authors: berchuck a. J Soc Gynecol Investig. 2004 Dec;11(8):501-2. doi: 10.1016/j.jsgi.2004.09.001. J Soc Gynecol Investig. 2004. PMID: 15582493 No abstract available.

2

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A. Spillman MA, et al. Among authors: berchuck a. Gynecol Oncol. 2005 May;97(2):543-9. doi: 10.1016/j.ygyno.2005.01.025. Gynecol Oncol. 2005. PMID: 15863158

3

Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.

Spillman MA, Lacy J, Murphy SK, Whitaker RS, Grace L, Teaberry V, Marks JR, Berchuck A. Spillman MA, et al. Among authors: berchuck a. Gynecol Oncol. 2007 May;105(2):312-20. doi: 10.1016/j.ygyno.2006.12.017. Epub 2007 Feb 5. Gynecol Oncol. 2007. PMID: 17276500 Free PMC article.

4

Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.

Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A. Murphy SK, et al. Among authors: berchuck a. Mol Cancer Res. 2006 Apr;4(4):283-92. doi: 10.1158/1541-7786.MCR-05-0138. Mol Cancer Res. 2006. PMID: 16603642

5

Gene expression patterns that characterize advanced stage serous ovarian cancers.

Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A. Lancaster JM, et al. Among authors: berchuck a. J Soc Gynecol Investig. 2004 Jan;11(1):51-9. doi: 10.1016/j.jsgi.2003.07.004. J Soc Gynecol Investig. 2004. PMID: 14706684

6

The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.

Jones MB, Houwink AP, Freeman BK, Greenwood TM, Lafky JM, Lingle WL, Berchuck A, Maxwell GL, Podratz KC, Maihle NJ. Jones MB, et al. Among authors: berchuck a. J Soc Gynecol Investig. 2006 May;13(4):304-11. doi: 10.1016/j.jsgi.2006.03.003. J Soc Gynecol Investig. 2006. PMID: 16697948

7

Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.

Havrilesky LJ, McMahon CP, Lobenhofer EK, Whitaker R, Marks JR, Berchuck A. Havrilesky LJ, et al. Among authors: berchuck a. J Soc Gynecol Investig. 2001 Mar-Apr;8(2):104-13. J Soc Gynecol Investig. 2001. PMID: 11336882

8

Pathogenesis of ovarian cancers.

Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC, Bast RC Jr. Berchuck A, et al. J Soc Gynecol Investig. 1994 Jul-Sep;1(3):181-90. doi: 10.1177/107155769400100302. J Soc Gynecol Investig. 1994. PMID: 9419769

9

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.

Wenham RM, Calingaert B, Ali S, McClean K, Whitaker R, Bentley R, Lancaster JM, Schildkraut J, Marks J, Berchuck A. Wenham RM, et al. Among authors: berchuck a. J Soc Gynecol Investig. 2003 Sep;10(6):381-7. doi: 10.1016/s1071-5576(03)00141-2. J Soc Gynecol Investig. 2003. PMID: 12969782

10

Human ovarian cancer of the surface epithelium.

Berchuck A, Carney M. Berchuck A, et al. Biochem Pharmacol. 1997 Sep 1;54(5):541-4. doi: 10.1016/s0006-2952(97)00061-0. Biochem Pharmacol. 1997. PMID: 9337069 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page